Table 3 Suggested safety measures during IS treatment with ACTH and vigabatrin
ACTH | Vigabatrin | |
|---|---|---|
Baseline hematology | X | X |
Baseline serum chemistries (i.e., SMA 20) | X | X |
Day 3 serum chemistries (especially potassium) | X | |
Twice weekly: | ||
Blood pressure | X | |
Stool guaiac | X | |
Urine glucose | X | |
Periodic ophthalmic evaluations and visual history | X | |
Periodic clinical exam and review of potential side effects | X | X |